Home/Filings/5/0001144204-14-010097
5//SEC Filing

Intra-Cellular Therapies, Inc. 5

Accession 0001144204-14-010097

CIK 0001567514operating

Filed

Feb 13, 7:00 PM ET

Accepted

Feb 14, 9:33 PM ET

Size

12.7 KB

Accession

0001144204-14-010097

Insider Transaction Report

Form 5
Period: 2013-08-29
Transactions
  • Disposition from Tender

    Common Stock, par value $0.0001 per share ("Common Stock")

    2013-08-29$0.01/sh5,000,000$60,0000 total
  • Disposition from Tender

    Common Stock

    2013-08-29$0.01/sh5,000,000$60,0000 total(indirect: Footnote)
  • Disposition from Tender

    Common Stock

    2013-08-29$0.01/sh5,000,000$60,0000 total(indirect: Footnote)
Transactions
  • Disposition from Tender

    Common Stock, par value $0.0001 per share ("Common Stock")

    2013-08-29$0.01/sh5,000,000$60,0000 total
  • Disposition from Tender

    Common Stock

    2013-08-29$0.01/sh5,000,000$60,0000 total(indirect: Footnote)
  • Disposition from Tender

    Common Stock

    2013-08-29$0.01/sh5,000,000$60,0000 total(indirect: Footnote)
LOW NATHAN A
10% Owner
Transactions
  • Disposition from Tender

    Common Stock, par value $0.0001 per share ("Common Stock")

    2013-08-29$0.01/sh5,000,000$60,0000 total
  • Disposition from Tender

    Common Stock

    2013-08-29$0.01/sh5,000,000$60,0000 total(indirect: Footnote)
  • Disposition from Tender

    Common Stock

    2013-08-29$0.01/sh5,000,000$60,0000 total(indirect: Footnote)
Footnotes (3)
  • [F1]On August 29, 2013, the issuer repurchased 5,000,000 shares of common stock for an aggregate purchase price of $60,000 from NLBDIT 2010 Services, LLC (the "Reporting Person") in connection with a change in control transaction.
  • [F2]Represents the shares of common stock owned of record by the Reporting Person and beneficially by The Nathan Low 2008 Irrevocable Trust ("Low Trust"). The Low Trust owns 100% of the outstanding membership interests of the Reporting Person and may be deemed to beneficially own the shares of common stock held of record by the Reporting Person.
  • [F3]Represents the shares of Common Stock owned of record by the Reporting Person and beneficially by Nathan A. Low. Mr. Low is the family trustee of the Low Trust and has voting and dispositive control over any securities owned of record or beneficially by the Low Trust. Therefore, Mr. Low may be deemed to beneficially own the shares of common stock held by the Reporting Person.

Issuer

Intra-Cellular Therapies, Inc.

CIK 0001567514

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001567514

Filing Metadata

Form type
5
Filed
Feb 13, 7:00 PM ET
Accepted
Feb 14, 9:33 PM ET
Size
12.7 KB